Empagliflozin and progression of kidney disease in type 2 diabetes
Wanner C, Inzucchi SE, Lachin JM, et al.; for the EMPA-REG OUTCOME Investigators N Engl J Med 2016, June 14 http://www.nejm.org/doi/full/10.1056/NEJMoa1515920?query=OF
Leggi
Is statin monotherapy the perfect polypill?
Ridker PM Circulation 2016;134:91-93 http://circ.ahajournals.org/content/134/2/91.extract
Leggi
Association of pharmacological treatments for obesity with weight loss and adverse events
Khera R, Murad MH, Chandar AK, et al. JAMA 2016;315:2424-34 http://jama.jamanetwork.com/article.aspx?articleID=2528211
Leggi
Is the mortality benefit with empagliflozin in type 2 diabetes mellitus too good to be true?
Kaul S Circulation 2016;134:94-96 http://circ.ahajournals.org/content/134/2/94.extract
Leggi
Cardiac and renovascular complications in type 2 diabetes – Is there hope?
Ingelfinger JR and Rosen CJ N Engl J Med 2016, June 14 http://www.nejm.org/doi/full/10.1056/NEJMe1607413?query=OF
Leggi
The genetic architecture of type 2 diabetes
Fuchsberger C, Flannick J, Teslovich TM, et al. Nature. Pub. online 11 July 2016 http://www.nature.com/nature/journal/vaop/ncurrent/full/nature18642.html
Leggi
Infections in Early Life and Development of Type 1 Diabetes
Beyerlein A, Donnachie E, Jergens S, Ziegler A-G JAMA 2016;315(17):1899-901 http://jama.jamanetwork.com/article.aspx?articleid=2518250
Leggi
Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: a randomized, controlled trial
Ali MK, Singh K, Kondal D, on behalf of the CARRS Trial Group Ann Intern Med. Pub. online 12 July 2016 http://annals.org/article.aspx?articleid=2533149
Leggi
Mortality Among Patients Hospitalized With Heart Failure and Diabetes Mellitus: Results From the National Inpatient Sample 2000 to 2010
Win TT, Davis HT and Laskey WK Circ Heart Fail. 2016;9:e003023 http://circheartfailure.ahajournals.org/content/9/5/e003023.abstract
Leggi
BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants
Aune D, Sen A, Prasad M, et al. BMJ 2016;353:i2156 http://www.bmj.com/content/353/bmj.i2156
Leggi